EUVIMEDEUVIMED entdecken
Crossref

Erzhi pill enhances methotrexate efficacy in rheumatoid arthritis bone homeostasis via activation of the IDO1-KYN-AhR pathway

Xiaoya Li, Xingyu Liu, Qinbin Ye, Shengchen Wang, Xiaoyu Xi, Jingyi Jiang, Xiaoshuang Mao, Meirong Fang, Wen Jin, Cheng Xiao

Phytomedicine · 2026-07 · 157 · 158290

DOI: 10.1016/j.phymed.2026.158290 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026-07. Verfasst von Xiaoya Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China; State Key La…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Indoleamine-Pyrrole 2,3,-Dioxygenase, Methotrexate, Arthritis, Rheumatoid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences Initiative for Innovative Medicine, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Progressive joint destruction and systemic bone loss are key factors contributing to disability and secondary osteoporosis in rheumatoid arthritis (RA). However, current clinical drugs, including first-line methotrexate (MTX), provide limited bone protection. Enhancing the regulatory effect of MTX on RA bone homeostasis through combination with traditional Chinese medicine (TCM) may offer a new perspective for RA treatment. This study investigated whether Erzhi pill (EZP), a kidney-tonifying TCM formula, enhances MTX efficacy in regulating bone homeostasis in RA via the IDO1-KYN-AhR signaling pathway. Using primary osteoblast/osteoclast models and a kidney deficiency collagen-induced arthritis (KD-CIA) rat model, we demonstrated that the MTX+EZP combination was superior to MTX monotherapy in promoting osteoblast differentiation/function, suppressing osteoclastogenesis, and mitigating bone destruction and loss in KD-CIA rats. These effects were associated with the restoration of suppressed IDO1-KYN-AhR signaling activity. Furthermore, siRNA-mediated knockdown or pharmacological inhibition of IDO1 or AhR reversed the regulatory effects of MTX+EZP on osteoblast-osteoclast differentiation/function and its bone-protective actions in KD-CIA rats. Finally, salidroside and ferulic acid were identified as the potential active compounds in EZP responsible for synergizing with MTX. In summary, our findings demonstrate that EZP enhances the efficacy of MTX in regulating RA bone homeostasis by activating the IDO1-KYN-AhR signaling pathway, representing a promising integrative strategy for managing RA-induced bone metabolism disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalIndoleamine-Pyrrole 2,3,-DioxygenaseMethotrexateArthritis, RheumatoidAnimalsHomeostasisSignal TransductionOsteoblastsRatsOsteoclastsRats, Sprague-DawleyMaleOsteogenesisArthritis, ExperimentalCell DifferentiationBone and BonesKynurenine

Stichwörter der Autor:innen

Bone homeostasisErzhi pillIDO1-KYN-AhR signaling pathwayMethotrexateRheumatoid arthritis

Substanzen

Drugs, Chinese HerbalIndoleamine-Pyrrole 2,3,-DioxygenaseMethotrexateIdo1 protein, ratKynurenine

Autor:innen und Institutionen

  • The Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China; State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Be…
  • The Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China. Electronic address: lxingyu0818@163.com.
  • School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China. Electronic address: 13687979191@163.com.
  • The Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China. Electronic address: 18810055837@163.com.
  • School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China. Electronic address: 17310270931@163.com.
  • The Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China. Electronic address: s2024009007@student.pumc.edu.cn.

Förderung

  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine
  • National Natural Science Foundation of China

Zitieren

APA

Li, X., Liu, X., Ye, Q., Wang, S., Xi, X., Jiang, J., Mao, X., Fang, M., Jin, W., & Xiao, C. (2026). Erzhi pill enhances methotrexate efficacy in rheumatoid arthritis bone homeostasis via activation of the IDO1-KYN-AhR pathway. Phytomedicine, 157, 158290. https://doi.org/10.1016/j.phymed.2026.158290

Vancouver

Li X, Liu X, Ye Q, Wang S, Xi X, Jiang J, et al. Erzhi pill enhances methotrexate efficacy in rheumatoid arthritis bone homeostasis via activation of the IDO1-KYN-AhR pathway. Phytomedicine. 2026;157:158290. doi:10.1016/j.phymed.2026.158290

BibTeX
@article{Li2026,
  author = {Li, Xiaoya and Liu, Xingyu and Ye, Qinbin and Wang, Shengchen and Xi, Xiaoyu and Jiang, Jingyi and Mao, Xiaoshuang and Fang, Meirong and Jin, Wen and Xiao, Cheng},
  title = {Erzhi pill enhances methotrexate efficacy in rheumatoid arthritis bone homeostasis via activation of the IDO1-KYN-AhR pathway},
  journal = {Phytomedicine},
  year = {2026},
  volume = {157},
  pages = {158290},
  doi = {10.1016/j.phymed.2026.158290}
}
Kostenlos starten →